We are live on ! Find out more
SK

Seth Klarman Baupost Group

AUM $5.42B
1-Year Est. Return 22.93%
 

Seth Klarman is the founder and CEO of the Baupost Group, one of the most respected value-oriented investment firms. He is the author of Margin of Safety and is known for patient, opportunistic capital allocation across equities, credit, and special situations. Klarman’s approach emphasizes downside protection, cash when opportunities are scarce, and independent thinking when markets become crowded.

This Fund
S&P 500
This Quarter Est. Return
-2.24%
1 Year Est. Return
+22.93%
3 Year Est. Return
+47.86%
5 Year Est. Return
+25.7%
10 Year Est. Return
+163.46%
AUM
$8.02B
AUM Growth
-$730M
Cap. Flow
-$462M
Cap. Flow %
-5.75%
Top 10 Hldgs %
78.13%
Holding
45
New
5
Increased
7
Reduced
4
Closed
8

Sector Composition

Rank Sector Weight
1 Energy 23.55%
2 Technology 22.35%
3 Healthcare 21.95%
4 Financials 19.4%
5 Communication Services 9.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LNG icon
1
Cheniere Energy
LNG
$57.3B
$934M 11.64%
20,726,340
SYF icon
2
Synchrony
SYF
$25.9B
$910M 11.34%
29,295,030
VSAT icon
3
Viasat
VSAT
$10.3B
$846M 10.55%
13,158,137
QRVO icon
4
Qorvo
QRVO
$8.43B
$636M 7.93%
9,000,000
AGN
5
DELISTED
Allergan plc
AGN
$608M 7.57%
2,964,203
+531,600
+22% +$124M
DBRG icon
6
DigitalBridge
DBRG
$2.95B
$602M 7.5%
11,976,365
TFCFA
7
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$505M 6.29%
19,137,469
AR icon
8
Antero Resources
AR
$11.7B
$476M 5.93%
23,912,257
+2,741,261
+13% +$55.2M
PBF icon
9
PBF Energy
PBF
$8.72B
$434M 5.41%
15,724,175
TBPH icon
10
Theravance Biopharma
TBPH
$883M
$319M 3.97%
9,309,168
+35,177
+0.4% +$1.15M
DELL icon
11
Dell
DELL
$286B
$236M 2.94%
10,876,638
-9,264,419
-46% -$179M
TFCF
12
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
$190M 2.37%
7,384,542
+106,442
+1% +$2.89M
KERX
13
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$183M 2.28%
25,791,678
CAH icon
14
Cardinal Health
CAH
$53.4B
$169M 2.11%
2,530,000
+500,000
+25% +$35.3M
ESRX
15
DELISTED
Express Scripts Holding Company
ESRX
$162M 2.02%
2,556,891
VRTV
16
DELISTED
VERITIV CORPORATION
VRTV
$99.2M 1.24%
3,053,724
+9,339
+0.3% +$312K
ATRA icon
17
Atara Biotherapeutics
ATRA
$97.4M
$88.7M 1.11%
214,385
MCK icon
18
McKesson
MCK
$100B
$76.8M 0.96%
+500,000
New +$78M
PRTK
19
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$60.1M 0.75%
2,394,498
IMOS
20
ChipMOS TECHNOLOGIES
IMOS
$1.88B
$58.9M 0.73%
2,588,002
-391,867
-13% -$8.69M
AMC icon
21
AMC Entertainment Holdings
AMC
$2.28B
$52.4M 0.65%
+356,536
New +$59.5M
GTYHU
22
DELISTED
GTY Technology Holdings, Inc. Units
GTYHU
$46M 0.57%
4,400,000
PR
23
Permian Resources
PR
$19.9B
$42.1M 0.52%
2,407,153
CAR icon
24
Avis
CAR
$5.18B
$39.5M 0.49%
1,036,900
-2,963,100
-74% -$99.6M
FWP
25
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$39.2M 0.49%
923,324
+14,173
+2% +$1.97M

Similar funds

Seth Klarman's Q3 2017 Portfolio in Review

As of Q3 2017, Seth Klarman held 45 positions worth $8.02B, down 8.3% from $8.75B the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Seth Klarman withdrew a net $462M in Q3 2017, closing 8 positions and reducing 4 holdings. Its most notable exit was Qualcomm, an estimated $288M position sold in full.

By sector, the portfolio is most concentrated in Energy at 24% of assets, up from 21% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Seth Klarman opened a new position in McKesson worth $76.8M.

  • Seth Klarman's largest Q3 2017 buy was McKesson: 500,000 shares worth $76.8M.
  • Seth Klarman added most to Allergan plc in Q3 2017, an estimated $124M increase.
  • Seth Klarman's biggest Q3 2017 reduction was Dell, cutting an estimated $179M.
  • Seth Klarman fully exited Qualcomm in Q3 2017, selling an estimated $288M.
  • Seth Klarman's ten largest holdings make up 78% of its $8.02B portfolio in Q3 2017.
  • Seth Klarman opened 5 new positions and closed 8 in Q3 2017.
  • Seth Klarman's portfolio value fell 8.3% quarter-over-quarter to $8.02B.

Based on Baupost Group's 13F filing for Q3 2017, filed 13 Nov 2017.